Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1989 Mar;57(3):810–816. doi: 10.1128/iai.57.3.810-816.1989

Rat alveolar macrophage production of chemoattractants for neutrophils: response to Escherichia coli endotoxin.

J W Christman 1, S F Petras 1, P M Vacek 1, G S Davis 1
PMCID: PMC313181  PMID: 2645210

Abstract

Endotoxemia in rats is associated with the accumulation of neutrophils (polymorphonuclear leukocytes) within the airspaces of the lung. Polymorphonuclear leukocyte influx appears to be regulated by the intrapulmonary accumulation of chemotactic activity. Since alveolar macrophages (AMS) are prevalent cells in the airspace and are known to release a variety of chemotactic factors, we investigated the effect of endotoxin exposure on AM production of chemotactic activity. We tested the hypothesis that endotoxin-exposed AMs have an augmented ability to produce chemoattractants. We recovered AMs by bronchoalveolar lavage from control rats and from rats treated in vivo with a "low dose" (2.5 mg/kg) or a "high dose" (5.0 mg/kg) of Escherichia coli endotoxin. These AMs were then cultured in vitro for 15 h in the absence or the presence of endotoxin (15 and 30 micrograms/ml) to stimulate the cells to produce chemoattractants. We found that in vitro endotoxin stimulated normal AMs to secrete chemoattractants in a dose-dependent fashion. AMs from rats treated with endotoxin in vivo spontaneously secreted more chemoattractants than AMs from control rats. Exposure to in vivo endotoxin followed by in vitro stimulation with endotoxin resulted in an even greater production of chemoattractants by AMs. We found a significant association between the percent polymorphonuclear leukocytes recovered by bronchoalveolar lavage from the airspaces and the production of chemoattractants by AMs from the same specimen. The level of chemotactic activity spontaneously produced by AMs predicted the degree of stimulated production of chemotactic activity. Partial purification indicated that this chemotactic activity has two molecular weight peaks, one near 1,000 and the other near 50,000. The activity was stable at 100 degrees C for at least 30 min and was degradable by trypsinization. We conclude that endotoxin can induce AM production of chemoattractants and that prior exposure to endotoxin in vivo affects the response of AM to in vitro endotoxin exposure. By inference, it is possible that this endotoxin-macrophage interaction may serve as a biologic amplifier of the effects of endotoxin and may have a role in the pathogenesis of septic lung injury in humans.

Full text

PDF
810

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aggarwal B. B., Kohr W. J., Hass P. E., Moffat B., Spencer S. A., Henzel W. J., Bringman T. S., Nedwin G. E., Goeddel D. V., Harkins R. N. Human tumor necrosis factor. Production, purification, and characterization. J Biol Chem. 1985 Feb 25;260(4):2345–2354. [PubMed] [Google Scholar]
  2. Bell R. C., Coalson J. J., Smith J. D., Johanson W. G., Jr Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med. 1983 Sep;99(3):293–298. doi: 10.7326/0003-4819-99-3-293. [DOI] [PubMed] [Google Scholar]
  3. Bendtzen K. Biological properties of interleukins. Allergy. 1983 May;38(4):219–226. doi: 10.1111/j.1398-9995.1983.tb01614.x. [DOI] [PubMed] [Google Scholar]
  4. Chang J. C., Lesser M. Quantitation of leukocytes in bronchoalveolar lavage samples from rats after intravascular injection of endotoxin. Am Rev Respir Dis. 1984 Jan;129(1):72–75. doi: 10.1164/arrd.1984.129.1.72. [DOI] [PubMed] [Google Scholar]
  5. Davis W. B., Barsoum I. S., Ramwell P. W., Yeager H., Jr Human alveolar macrophages: effects of endotoxin in vitro. Infect Immun. 1980 Dec;30(3):753–758. doi: 10.1128/iai.30.3.753-758.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Deuel T. F., Senior R. M., Huang J. S., Griffin G. L. Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J Clin Invest. 1982 Apr;69(4):1046–1049. doi: 10.1172/JCI110509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dinarello C. A. Interleukin-1 and the pathogenesis of the acute-phase response. N Engl J Med. 1984 Nov 29;311(22):1413–1418. doi: 10.1056/NEJM198411293112205. [DOI] [PubMed] [Google Scholar]
  8. Eiermann G. J., Dickey B. F., Thrall R. S. Polymorphonuclear leukocyte participation in acute oleic-acid-induced lung injury. Am Rev Respir Dis. 1983 Nov;128(5):845–850. doi: 10.1164/arrd.1983.128.5.845. [DOI] [PubMed] [Google Scholar]
  9. Hunninghake G. W., Gadek J. E., Lawley T. J., Crystal R. G. Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest. 1981 Jul;68(1):259–269. doi: 10.1172/JCI110242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kaplan R. L., Sahn S. A., Petty T. L. Incidence and outcome of the respiratory distress syndrome in gram-negative sepsis. Arch Intern Med. 1979 Aug;139(8):867–869. [PubMed] [Google Scholar]
  11. Kovacs E. J., Kelley J. Intra-alveolar release of a competence-type growth factor after lung injury. Am Rev Respir Dis. 1986 Jan;133(1):68–72. doi: 10.1164/arrd.1986.133.1.68. [DOI] [PubMed] [Google Scholar]
  12. Kovacs E. J., Kelley J. Secretion of macrophage-derived growth factor during acute lung injury induced by bleomycin. J Leukoc Biol. 1985 Jan;37(1):1–14. doi: 10.1002/jlb.37.1.1. [DOI] [PubMed] [Google Scholar]
  13. Kownatzki E., Kapp A., Uhrich S. Novel neutrophil chemotactic factor derived from human peripheral blood mononuclear leucocytes. Clin Exp Immunol. 1986 Apr;64(1):214–222. [PMC free article] [PubMed] [Google Scholar]
  14. Kreisle R. A., Parker C. W., Griffin G. L., Senior R. M., Stenson W. F. Studies of leukotriene B4-specific binding and function in rat polymorphonuclear leukocytes: absence of a chemotactic response. J Immunol. 1985 May;134(5):3356–3363. [PubMed] [Google Scholar]
  15. Martin T. R., Altman L. C., Albert R. K., Henderson W. R. Leukotriene B4 production by the human alveolar macrophage: a potential mechanism for amplifying inflammation in the lung. Am Rev Respir Dis. 1984 Jan;129(1):106–111. doi: 10.1164/arrd.1984.129.1.106. [DOI] [PubMed] [Google Scholar]
  16. Merrill W. W., Naegel G. P., Matthay R. A., Reynolds H. Y. Alveolar macrophage-derived chemotactic factor: kinetics of in vitro production and partial characterization. J Clin Invest. 1980 Feb;65(2):268–276. doi: 10.1172/JCI109668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Montgomery A. B., Stager M. A., Carrico C. J., Hudson L. D. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1985 Sep;132(3):485–489. doi: 10.1164/arrd.1985.132.3.485. [DOI] [PubMed] [Google Scholar]
  18. Morrison D. C., Ulevitch R. J. The effects of bacterial endotoxins on host mediation systems. A review. Am J Pathol. 1978 Nov;93(2):526–618. [PMC free article] [PubMed] [Google Scholar]
  19. Rinaldo J. E., Dauber J. H., Christman J., Rogers R. M. Neutrophil alveolitis following endotoxemia. Enhancement by previous exposure to hyperoxia. Am Rev Respir Dis. 1984 Dec;130(6):1065–1071. doi: 10.1164/arrd.1984.130.6.1065. [DOI] [PubMed] [Google Scholar]
  20. Rinaldo J. E., Henson J. E., Dauber J. H., Henson P. M. Role of alveolar macrophages in endotoxin-induced neutrophilic alveolitis in rats. Tissue Cell. 1985;17(4):461–472. doi: 10.1016/0040-8166(85)90025-4. [DOI] [PubMed] [Google Scholar]
  21. Shands J. W., Jr, Peavy D. L., Gormus B. J., McGraw J. In vitro and in vivo effects of endotoxin on mouse peritoneal cells. Infect Immun. 1974 Jan;9(1):106–112. doi: 10.1128/iai.9.1.106-112.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Snella M. C. Production of a neutrophil chemotactic factor by endotoxin stimulated alveolar macrophages in vitro. Br J Exp Pathol. 1986 Dec;67(6):801–807. [PMC free article] [PubMed] [Google Scholar]
  23. Snyderman R., Shin H., Dannenberg A. M., Jr Macrophage proteinase and inflammation: the production of chemotactic activity from the fifth complement by macrophage proteinase. J Immunol. 1972 Oct;109(4):896–898. [PubMed] [Google Scholar]
  24. Tate R. M., Repine J. E. Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis. 1983 Sep;128(3):552–559. doi: 10.1164/arrd.1983.128.3.552. [DOI] [PubMed] [Google Scholar]
  25. Yoshimura T., Matsushima K., Oppenheim J. J., Leonard E. J. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1). J Immunol. 1987 Aug 1;139(3):788–793. [PubMed] [Google Scholar]
  26. Zigmond S. H., Hirsch J. G. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med. 1973 Feb 1;137(2):387–410. doi: 10.1084/jem.137.2.387. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES